Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants

The emerging variants of SARS coronavirus-2 (SARS-CoV-2) have been continuously spreading all over the world and have raised global health concerns. The B.1.1.7 (United Kingdom), P.1 (Brazil), B.1.351 (South Africa) and B.1.617 (India) variants, resulting from multiple mutations in the spike glycopr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferdous, Nadim, Reza, Mahjerin Nasrin, Islam, Md. Shariful, Hossain Emon, Md. Tabassum, Mohiuddin, A. K. M., Hossain, Mohammad Uzzal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041434/
https://www.ncbi.nlm.nih.gov/pubmed/35496863
http://dx.doi.org/10.1039/d1ra04107j

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041434/
https://www.ncbi.nlm.nih.gov/pubmed/35496863
http://dx.doi.org/10.1039/d1ra04107j

Ejemplares similares